The high mortality and financial burden associated with prostate cancer can be partly
attributed to a lack of sensitive screening methods for detection and staging of the disease …

Prostate-specific membrane antigen (PSMA) is highly expressed in prostate cancer, and
small-molecule radiopharmaceuticals targeting PSMA rapidly detect the location and extent …

Prostate cancer (PCa) is a major cause of mortality and morbidity in Western society today.
Current methods for detecting PCa are limited, leaving most early malignancies …

BACKGROUND Prostate‐specific membrane antigen (PSMA) remains an active target for
imaging and therapeutic applications for prostate cancer. METHODS In the present study, an …

Prostate-specific membrane antigen (PSMA) is a well-established target for nuclear imaging
and therapy of prostate cancer (PCa). Radiolabeled small-molecule PSMA inhibitors are …

Technetium-99m, the most commonly used radionuclide in nuclear medicine, can be
attached to biologically important molecules through a variety of chelating agents, the choice …

Purpose: Prostate-specific membrane antigen (PSMA) is a cell surface protein that is
overexpressed in prostate cancer, including hormone-refractory and metastatic disease. Our …

Prostate-specific membrane antigen (PSMA) is a well-established target for developing
radiopharmaceuticals for imaging and therapy of prostate cancer (PCa). We have recently …

The application of small molecules targeting prostate-specific membrane antigen (PSMA)
has emerged as a highly promising clinical strategy for visualization and treatment of …

In the past two decades, extensive efforts have been made to develop agents targeting
prostate-specific membrane antigen (PSMA) for prostate cancer imaging and therapy. To …